Description of Research Expertise:
Dr. Katz is a thoracic radiologist at the Hospital of the University of Pennylvania. Her research is focused on improving clinical measures of therapeutic response to therapy in thoracic malignancy with a special emphasis on PET imaging markers of metabolism.
Selected recent Publications (please follow Pubmed link below for additional publications)
Early detection of thymidylate synthase resistance in non-small cell lung cancer with FLT-PET imaging.
Chen X, Yang Y, Katz S. Oncotarget. 2017
Early detection of pemetrexed-induced inhibition of thymidylate synthase in non-small cell lung cancer with FLT-PET imaging.
Chen X, Yang Y, Berger I, Khalid U, Patel A, Cai J, Farwell MD, Langer C, Aggarwal C, Albelda SM, Katz SI. Oncotarget. 2017; 8(15):24213-24223.
Immunotherapy and radiation therapy for malignant pleural mesothelioma.
Alley EW, Katz SI, Cengel KA, Simone CB 2nd.
Translational lung cancer research. 2017; 6(2):212-219.
North American Multicenter Volumetric CT Study for Clinical Staging of Malignant Pleural Mesothelioma: Feasibility and Logistics of Setting Up a Quantitative Imaging Study.
Gill RR, Naidich DP, Mitchell A, Ginsberg M, Erasmus J, Armato SG 3rd, Straus C, Katz S, Patios D, Richards WG, Rusch VW.
A Multicenter Study of Volumetric Computed Tomography for Staging Malignant Pleural Mesothelioma.
Rusch VW, Gill R, Mitchell A, Naidich D, Rice DC, Pass HI, Kindler HL, De Perrot M, Friedberg J. Malignant Mesothelioma Volumetric CT Study Group. The Annals of thoracic surgery. 2016; 102(4):1059-66.